CHEN BIHUA (CEO and Chairman) sold 76.5% of their position (6.50M shares) of MOONLAKE IMMUNOTHERAPEUTICS on the open market
Open‑market sale worth $46.87M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 10/1/2025ACC: 0000929638-25-003712
DirectorOfficer10% Owner· CEO and Chairman
Since Oct 2020
-6.50M
Net shares
Net seller
$46.87M
Total sold
5
Open market trades
0B · 5S
5
Total transactions
6.50M disposed
Non-Derivative Transactions5
Class A Ordinary Shares
Indirect
Shares
−70.75K
Price / share
$9.38
Trade value
$663.62K
% of position
0.8%
9/29/2025
8.49M→8.42M
Class A Ordinary Shares
Indirect
Shares
−232.46K
Price / share
$8.40
Trade value
$1.95M
% of position
2.8%
9/29/2025
8.42M→8.19M
Class A Ordinary Shares
Indirect
Shares
−3.39M
Price / share
$7.58
Trade value
$25.70M
% of position
41.4%
9/29/2025
8.19M→4.80M
Class A Ordinary Shares
Indirect
Shares
−2.80M
Price / share
$6.61
Trade value
$18.51M
% of position
58.3%
9/29/2025
4.80M→2M
Class A Ordinary Shares
Indirect
Shares
−5.83K
Price / share
$6.96
Trade value
$40.56K
% of position
0.3%
9/30/2025
2M→1.99M
Total
Net shares
−6.50M
Net value
-$46.87M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares Indirect | 9/29/2025 | S · Sale | −70.75K | $9.38 | $663.62K | 0.8% | 8.49M | 8.42M |
| Class A Ordinary Shares Indirect | 9/29/2025 | S · Sale | −232.46K | $8.40 | $1.95M | 2.8% | 8.42M | 8.19M |
| Class A Ordinary Shares Indirect | 9/29/2025 | S · Sale | −3.39M | $7.58 | $25.70M | 41.4% | 8.19M | 4.80M |
| Class A Ordinary Shares Indirect | 9/29/2025 | S · Sale | −2.80M | $6.61 | $18.51M | 58.3% | 4.80M | 2M |
| Class A Ordinary Shares Indirect | 9/30/2025 | S · Sale | −5.83K | $6.96 | $40.56K | 0.3% | 2M | 1.99M |
| Total | −6.50M | -$46.87M | ||||||
Derivative Transactions0
No derivative transactions reported